Brief: VBL Therapeutics Reports Third Quarter 2022 Financial Results
14/11/2022 21:32
Nov 14 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* VASCULAR BIOGENICS LTD- QTRLY NET LOSS $9.2 MILLION,
OR$0.12 PER
SHARE
Source text for Eikon: ID:nGNX6LhBp0
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives